默克藥廠MRK
紐約證券 · USD
150.33
-2.01
(-1.32%)
收盤 09/05 03:59 (UTC+8)
盤後
150.51
+0.18
(+0.12%)
09/05 03:59 (UTC+8)
默克藥廠MRK
150.33
-2.01
(-1.32%)
財務數據
損益表
- 157.75
- 161.12
- 166.57
- 156.24
- 155.29
- 158.06
- 172.76
- 164.00
- 162.86
- 166.07
- 7.83
- 2.14
- 3.38
- -6.20
- -0.61
- 1.78
- 9.30
- -5.07
- -0.70
- 1.97
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 16,607,000 | 16,286,000 | 16,400,000 | 17,276,000 | 15,806,000 | 15,529,000 | 15,624,000 | 16,657,000 | 16,112,000 | 15,775,000 |
營業成本 | 4,395,000 | 4,195,000 | 5,551,000 | 3,855,000 | 3,557,000 | 3,419,000 | 3,828,000 | 4,080,000 | 3,745,000 | 3,540,000 |
營業毛利 | 12,212,000 | 12,091,000 | 10,849,000 | 13,421,000 | 12,249,000 | 12,110,000 | 11,796,000 | 12,577,000 | 12,367,000 | 12,235,000 |
營業費用 | 12,796,000 | 15,487,000 | 6,997,000 | 6,914,000 | 7,258,000 | - | - | 8,649,000 | - | 6,598,000 |
研發費用 | 9,741,000 | 12,592,000 | 3,886,000 | 4,234,000 | 4,048,000 | 3,621,000 | 4,584,000 | 5,862,000 | 3,500,000 | 3,992,000 |
推銷及管理費用 | 2,904,000 | 2,700,000 | 2,898,000 | 2,633,000 | 2,650,000 | 2,552,000 | 2,864,000 | 2,731,000 | 2,738,000 | 2,483,000 |
非經常性項目費用 | 151,000 | 195,000 | 213,000 | 47,000 | 560,000 | 69,000 | 51,000 | 56,000 | 79,000 | 123,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -584,000 | -3,396,000 | 3,852,000 | 6,507,000 | 4,991,000 | 5,868,000 | 4,297,000 | 3,928,000 | 6,050,000 | 5,637,000 |
其他收入及費用 | -99,000 | -138,000 | -432,000 | 238,000 | 8,000 | 35,000 | -127,000 | 163,000 | -45,000 | 33,000 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -683,000 | -3,534,000 | 3,420,000 | 6,745,000 | 4,999,000 | 5,903,000 | 4,170,000 | 4,091,000 | 6,005,000 | 5,670,000 |
所得稅 | 654,000 | 709,000 | 458,000 | 958,000 | 570,000 | 818,000 | 426,000 | 930,000 | 544,000 | 903,000 |
稅後純益 | -1,335,000 | -4,240,000 | 2,963,000 | 5,785,000 | 4,427,000 | 5,079,000 | 3,743,000 | 3,157,000 | 5,455,000 | 4,762,000 |
基本每股稅後盈餘(元) | -0.54 | -1.72 | 1.20 | 2.33 | 1.77 | 2.02 | 1.48 | 1.25 | 2.15 | 1.88 |
稀釋每股稅後盈餘(元) | -0.54 | -1.72 | 1.20 | 2.31 | 1.76 | 2.01 | 1.48 | 1.24 | 2.15 | 1.87 |
基本平均股數(千股) | 2468643.00 | 2469693.00 | 2474626.00 | 2487348.00 | 2503140.00 | 2516081.00 | 2527637.00 | 2532030.00 | 2535649.00 | 2532700.00 |
稀釋平均股數(千股) | 2470000.00 | 2472000.00 | 2488000.00 | 2498000.00 | 2513000.00 | 2531000.00 | 2537000.00 | 2541000.00 | 2544000.00 | 2544000.00 |
還原基本每股稅後盈餘(元) | -0.54 | -1.72 | 1.20 | 2.33 | 1.77 | 2.02 | 1.48 | 1.25 | 2.15 | 1.88 |
還原稀釋每股稅後盈餘(元) | -0.54 | -1.72 | 1.20 | 2.31 | 1.76 | 2.01 | 1.48 | 1.24 | 2.15 | 1.87 |
還原基本平均股數(千股) | 2,468,643 | 2,469,693 | 2,474,626 | 2,487,348 | 2,503,140 | 2,516,081 | 2,527,637 | 2,532,030 | 2,535,649 | 2,532,700 |
還原稀釋平均股數(千股) | 2,470,000 | 2,472,000 | 2,488,000 | 2,498,000 | 2,513,000 | 2,531,000 | 2,537,000 | 2,541,000 | 2,544,000 | 2,544,000 |
EBITDA(千元) | 902,000 | -2,019,000 | 5,887,000 | 7,897,000 | 6,116,000 | 6,996,000 | 5,366,000 | 5,273,000 | 7,131,000 | 6,649,000 |